Jonathan Skinner
Dartmouth College
Public economicsInternal medicineConsumption (economics)SurgeryBusinessLabour economicsGovernmentDemographyHealth careActuarial scienceEconomicsReferralQuality (business)PopulationDemographic economicsFamily medicineMonetary economicsMedicineGerontology
369Publications
87H-index
17.5kCitations
Publications 272
Newest
#1Benjamin K. Couillard (U of T: University of Toronto)H-Index: 1
#2Christopher L. Foote (Federal Reserve Bank of Boston)H-Index: 6
Last. Jonathan Skinner (Dartmouth College)H-Index: 87
view all 5 authors...
Source
#1Lauren Gilstrap (Dartmouth College)H-Index: 10
#2Andrea M. Austin (Dartmouth College)H-Index: 10
Last. Jonathan Skinner (Dartmouth College)H-Index: 87
view all 8 authors...
Source
#1Amber E. Barnato (The Dartmouth Institute for Health Policy and Clinical Practice)H-Index: 52
#2John D. Birkmeyer (The Dartmouth Institute for Health Policy and Clinical Practice)H-Index: 3
Last. Nancy Birkmeyer (The Dartmouth Institute for Health Policy and Clinical Practice)H-Index: 1
view all 5 authors...
BACKGROUND: We sought to determine whether dementia is associated with treatment intensity and mortality in patients hospitalized with COVID-19. METHODS: This study includes review of the medical records for patients >60 years of age (n = 5394) hospitalized with COVID-19 from 132 community hospitals between March and June 2020. We examined the relationships between dementia and treatment intensity (including intensive care unit [ICU] admission and mechanical ventilation [MV] and care processes t...
Source
Source
#1Olivia A. Sacks (BMC: Boston Medical Center)H-Index: 3
#2Amber E. Barnato (The Dartmouth Institute for Health Policy and Clinical Practice)H-Index: 52
Last. Nancy Birkmeyer (The Dartmouth Institute for Health Policy and Clinical Practice)H-Index: 1
view all 6 authors...
Source
Background Transcatheter aortic valve replacement (TAVR) has transformed the management of aortic valve stenosis. However, little national data are available characterizing the geographic and demographic dispersion of this disruptive technology relative to surgical aortic valve replacement (SAVR). Methods and Results In this US claims-based study, we analyzed a 100% sample of fee-for-service Medicare beneficiaries from 2012 to 2017 and examined national rates of TAVR versus SAVR. Procedure rates...
Source
#1Lauren Gilstrap (Dartmouth College)H-Index: 10
#2Andrea M. Austin (Dartmouth College)H-Index: 10
Last. Jonathan Skinner (Dartmouth College)H-Index: 87
view all 8 authors...
Background/objectives null Neurohormonal therapy, which includes beta-blockers and angiotensin-converting enzyme inhibitor/angiotensin receptor blockers (ACEi/ARBs), is the cornerstone of heart failure with reduced ejection fraction (HFrEF) treatment. While neurohormonal therapies have demonstrated efficacy in randomized clinical trials, older patients, which now comprise the majority of HFrEF patients, were underrepresented in those original trials. This study aimed to determine the association...
Source
#1Lauren Gilstrap (The Dartmouth Institute for Health Policy and Clinical Practice)H-Index: 10
#2Andrea M. Austin (The Dartmouth Institute for Health Policy and Clinical Practice)H-Index: 10
Last. Jonathan Skinner (The Dartmouth Institute for Health Policy and Clinical Practice)H-Index: 87
view all 7 authors...
BACKGROUND The demographics of heart failure are changing. The rate of growth of the "older" heart failure population, specifically those ≥ 75, has outpaced that of any other age group. These older patients were underrepresented in the early beta-blocker trials. There are several reasons, including a decreased potential for mortality benefit and increased risk of side effects, why the risk/benefit tradeoff may be different in this population. OBJECTIVE We aimed to determine the association betwe...
Source
#1Gregory M. Ouellet (Yale University)H-Index: 12
#2Terri R. FriedH-Index: 62
Last. Andrew B. CohenH-Index: 8
view all 7 authors...
This cross-sectional study evaluates the degree of anticoagulant use among nursing home residents with advanced dementia and atrial fibrillation at the end of life.
Source
#1A. James O'MalleyH-Index: 57
#2Thomas BubolzH-Index: 3
Last. Jonathan SkinnerH-Index: 87
view all 3 authors...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.